Shares of Tatva Chintan Pharma Chem Ltd. surged as much as 18% on Monday, July 20, after the specialty chemicals company reported a strong set of June quarter earnings, with revenue, operating profit and net profit registering sharp year-on-year growth.Revenue for the quarter rose 42% to ₹167 crore from ₹117 crore in the corresponding period last year.
Operating performance improved, with EBITDA climbing 88% year-on-year to ₹32.5 crore from ₹17.3 crore. The company’s EBITDA margin expanded to 19.5% from 14.7% a year earlier.Net profit more than doubled, rising 142% year-on-year to ₹16 crore from ₹6.6 crore in the year-ago quarter.
The June quarter also marked the company’s highest EBITDA in at least the last five quarters, continuing a steady improvement from ₹17 crore in Q1FY26 to ₹22 crore in Q2FY26, ₹25 crore in Q3FY26, ₹28 crore in Q4FY26 and ₹32.5 crore in Q1FY27.
Profit after tax also touched a multi-quarter high at ₹16 crore, compared with ₹10 crore in the previous quarter and ₹6.6 crore in the corresponding quarter last year, reflecting sustained improvement in profitability.
